Afghanistan
2 Vaccines Approved for Use in Afghanistan
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Approval Source: republicworld.com
Non Replicating Viral Vector
Serum Institute of India
Covishield (Oxford/ AstraZeneca formulation)
Approved in 49 countries
4 trials in 1 country
Approval Source: emro.who.int